Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$248,401
-$123,545 QoQ
Shares Held
1,585
-34.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,218
of 1,603 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Knights of Columbus Asset Advisors LLC holds $16,766,377 across 10 Drug Manufacturers - General names. NVS ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
109,712 | $13,861,014 | |
| 2 | LLY |
ELI LILLY & Co
|
1,091 | $1,308,578 | |
| 3 | JNJ |
Johnson & Johnson
|
1,421 | $360,891 | |
| 4 | ABBV |
AbbVie Inc.
|
1,391 | $350,031 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
4,940 | $284,642 | |
| 6 | NVS |
Novartis AG
This page
|
1,585 | $248,401 | |
| 7 | NVO |
Novo Nordisk A S
|
2,931 | $140,512 | |
| 8 | SNY |
Sanofi
|
2,405 | $102,597 |
All Filings in NVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248,401 | 1,585 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $371,946 | 2,435 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $5,352 | 55 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $6,326 | 55 | Shares | Sole | 2024-11-12 | |
| 2020-12-31 | $304,725 | 3,227 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $280,619 | 3,227 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $214,332 | 2,454 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $202,002 | 2,450 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||